Study of ZG005 in Patients With Advanced Solid Tumors
NCT06927687
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL:
ZG005 for Injection
Sponsor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd